Abstract
Early infantile epileptic encephalopathies (EIEEs) are caused by a variety of structural brain abnormalities, genetic defects and inborn errors of metabolism. Although most conditions do not have definitive treatment, a very few of these are treatable like pyridoxine dependency, pyridoxal phosphate–responsive seizures, folinic acid–responsive seizures, biotinidase deficiency, glucose transporter type 1 deficiency syndrome, creatine deficiency, and KCNQ2 and SCN2A encephalopathies.1 We now have another condition in EIEE that is easily treatable, i.e., EIEE-50 caused because of mutations in CAD gene that can be treated with uridine supplementation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
